Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-10 Sale |
2021-08-12 4:20 pm |
Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer |
51,785 | $17.6 | $911,416 | 176,073 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-10 Exercise |
2021-08-12 4:20 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer |
51,785 | $0 | 176,073 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-12 4:20 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer |
51,785 | $7.84 | 176,073 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:30 pm |
N/A 2031-02-07 |
Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2021-02-10 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer |
0 | $0 | 186,495 (Direct) |
View |